Form 8-K - Current report:
SEC Accession No. 0001601830-21-000016
Filing Date
2021-08-13
Accepted
2021-08-13 07:55:49
Documents
14
Period of Report
2021-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20210813.htm   iXBRL 8-K 32159
2 EX-99.1 exhibit991-q0221.htm EX-99.1 98811
6 GRAPHIC rxrx-20210630_g2a.jpg GRAPHIC 67994
  Complete submission text file 0001601830-21-000016.txt   387324

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20210813.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20210813_lab.xml EX-101.LAB 26985
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20210813_pre.xml EX-101.PRE 14271
7 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20210813_htm.xml XML 12029
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 211169769
SIC: 2836 Biological Products, (No Diagnostic Substances)